The role of syndecan-1 in malignancies

Annals of Medicine

Volumn 28, Issue 1, 1996, Pages 63-67

  Inki, Pirjo ^a,b   Jalkanen, Markku ^a  

^a TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Carcinoma; Cell adhesion; Growth factor; Heparan sulphate; Malignant transformation; Proteoglycan

Indexed keywords

GROWTH FACTOR; PROTEOGLYCAN; SYNDECAN;

CELL ADHESION; EMBRYO DEVELOPMENT; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HEAD AND NECK CARCINOMA; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA;

EID: 0030065003     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899608999076     Document Type: Review

References (32)

1. Bernfield M, Kokenyesi R, Kato M, et al. Biology of the syndecans. Annu Rev Cell Biol 1992; 8: 365-93.
2. Elenius K, Jalkanen M. Function of the syndecans - a family of cell surface proteoglycans. J Cell Sci 1994; 107: 2975-82.
3. Jalkanen M, Elenius K, Rapraeger A. Syndecan: regulator of cell morphology and growth factor action at the cell-matrix interface. Trends Glycosci Glycotechn 1993; 5: 107-20.
4. Rapraeger A. The coordinated regulation of heparan sulfate, syndecans and cell behavior. Curr Opin Cell Biol 1993; 5: 844-53.
5. Mali M, Jaakkola P, Arvilommi A-M, Jalkanen M. Sequence of human syndecan indicates a novel gene family of integral membrane proteoglycans. J Biol Chem 1990; 265: 6884-9.
6. Elenius K, Salmivirta M, Inki P, Mali M, Jalkanen M. Binding of human syndecan to extracellular matrix proteins. J Biol Chem 1990; 265: 17837-43.
7. Elenius K, Vainio S, Laato M, Salmivirta M, Thesleff I, Jalkanen M. Induced expression of syndecan in healing wounds. J Cell Biol 1991; 114: 585-95.
8. Salmivirta M, Elenius K, Vainio S, et al. Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 1991; 266: 7733-9.
9. Salmivirta M, Rauvala H, Elenius K, Jalkanen M. Neurite growth-promoting protein (amphoterin, p30), binds syndecan. Exp Cell Res 1992; 200: 444-51.
10. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor on intersittial matrix. J Cell Biol 1988; 106: 423-30.
11. Sanderson R, Sneed TB, Young LA, Sullivan GL, Lander AD. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by the integral membrane proteoglycan, syndecan. J Immunol 1992; 148: 3902-7.
12. Sanderson RD, Lalor P, Bernfield M. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1989; 1: 27-35.
13. Salmivirta M, Heino J, Jalkanen M. bFGF-syndecan complex at cell surface or immobilized to matrix proteins promotes cell growth. J Biol Chem 1992; 267: 17606-10.
14. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-8.
15. Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myogenic differentiation. Science 1991; 252: 1705-8.
16. Ornitz D, Leder P. Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J Biol Chem 1992; 267: 16305-11.
17. Kan M, Wang F, Xu J, Crabb JW, Hou J, McKeehan L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 1993; 259: 1918-21.
18. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79: 1005-13.
19. Maccarana M, Casu B, Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 1993; 268: 23898-05.
20. Gilbert SF. Developmental Biology, 3rd edn. Sunderland, MA: Sinauer Associates Inc., 1991.
21. Vainio S, Jalkanen M, Vaahtokari A, Sahlberg C, Mali M, Bernfield M. Expression of syndecan gene is induced early, is transient and correlates with changes in mesenchymal cell proliferation during tooth organogenesis. Dev Biol 1991; 147: 322-33.
22. Inki P, Stenbäck F, Talve L, Jalkanen M. Immunohistochemical localization of syndecan in mouse skin tumours induced by UV irradiation: loss of expression associated with malignant transformation. Am J Pathol 1991; 139: 1333-40.
23. Leppä S, Vleminckx K, Van Roy F, Jalkanen M. Syndecan-1 expression in mammary epithelial tumour cells is E-cadherin dependent (submitted).
24. Miettinen HM, Jalkanen M. The cytoplasmic domain of syndecan-1 is not required for association with the detergent-insoluble cytoskeleton. J Cell Sci 1994; 107: 1571-81.
25. Miettinen H, Edwards SN, Jalkanen M. Analysis of transport and targeting of syndecan-1: effect of cytoplasmic tail deletions. Mol Biol Cell 1994; 5: 1325-39.
26. Aznavoorian S, Murphy AN, Stetler-Stevenson WG, Liotta LA. Molecular aspects of tumour cell invasion and metastasis. Cancer 1992; 71: 1368-83.
27. Pusztai L, Lewis CE, Lorenzen J, McGee J. Growth factors: regulation of normal and neoplastic growth. J Pathol 1993; 169: 191-201.
28. Inki P, Goméz M, Quintanilla M, Cano A, Jalkanen M. Expression of syndecan in transformed mouse keratinocytes. Lab Invest 1992; 67: 225-33.
29. Leppä S, Mali M, Miettinen H, Jalkanen M. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumour cells. Proc Natl Acad Sci USA 1992; 89: 932-6.
30. Mali M, Andtfolk H, Miettinen HM, Jalkanen M. Suppression of tumour cell growth by syndecan-1 ectodomain. J Biol Chem 1994; 269: 27795-8.
31. Liebersbach BF, Sanderson RD. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem 1994; 269: 20013-9.
32. Inki P, Joensuu H, Grenman R, Klemi P, Jalkanen M. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck. Br J Cancer 1994; 70: 319-23.